What is it about?
Data on using a new cephalosporin via unique administration off-label.
Featured Image
Why is it important?
No published data currently exists on using this specific cephalosporin as a continuous infusion. In our case, being able to give the drug via this route allowed the patient to not have to be admitted to the hospital to receive therapy.
Read the Original
This page is a summary of: Use of Continuous-Infusion Ceftolozane/Tazobactam in a Multidrug-Resistant Pseudomonas aeruginosa Urinary Tract Infection in the Outpatient Setting, Annals of Pharmacotherapy, March 2017, SAGE Publications,
DOI: 10.1177/1060028017701938.
You can read the full text:
Contributors
The following have contributed to this page
